Biology of the Arterial Wall

List of Contributors. Preface B.I. Levy, A. Tedgui. I. The Vascular Wall under Physiological Conditions. 1. Morphologic aspects of the large artery vascular wall B.I. Levy, A. Tedgui. 2. Mechanics of the large artery vascular wall B.I. Levy. 3. Neurohumoral control of the vascular system S. Laurent. 4. Endothelial function and dysfunction P. Vanhoutte, C. Boulanger. 5. Mechanical factors and vascular biology A. Tedgui, et al. 7. Angiogenesis H.A.J. Struijker Boudier, et al. 8. Vascular aging J. Belmin. II. The Vascular Wall under Pathological Conditions. 9. Vessel and inflammation C. Bernard. 10. Apoptosis in normal and pathological vessels Z. Mallat, A. Tedgui. 11. Stiffness of wall material in human hypertension M.E. Safar. 12. Pathobiology of atherosclerosis A. Tedgui, et al. 13. Arterial gene transfer L.J. Feldmana, Ph. G. Steg. Index.

[1]  H. Lofland,et al.  Atherosclerosis in Cebus albifrons monkeys. [. Clinical and pathologic studies. , 1969, Experimental and molecular pathology.

[2]  W. Kannel,et al.  Evaluation of cardiovascular risk in the elderly: the Framingham study. , 1978, Bulletin of the New York Academy of Medicine.

[3]  S. Schwartz,et al.  Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[4]  S. Schwartz,et al.  Evidence for cell death in the vascular endothelium in vivo and in vitro. , 1983, The American journal of pathology.

[5]  P. Morméde,et al.  Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. , 1985, Biochemical and biophysical research communications.

[6]  A. Cerami,et al.  Rapid Publications Nonenzymatic Glycosylation Products on Collagen Covalently Trap Low-Density Lipoprotein , 1985 .

[7]  S. Schwartz,et al.  Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. , 1985, The American journal of pathology.

[8]  A. Baird,et al.  Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. , 1986, Biochemical and biophysical research communications.

[9]  J. Fiddes,et al.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.

[10]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[11]  M. Klagsbrun,et al.  Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet‐derived growth factor‐like protein which is secreted , 1987, Journal of cellular physiology.

[12]  G. Bianciardi,et al.  Atherosclerosis and aging. A morphometric study on arterial lesions of elderly and very elderly necropsy subjects. , 1988, Archives of pathology & laboratory medicine.

[13]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[14]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[15]  D. Connolly,et al.  Human vascular permeability factor. Isolation from U937 cells. , 1989, The Journal of biological chemistry.

[16]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[17]  J. Montani,et al.  Growth regulation of the vascular system: evidence for a metabolic hypothesis. , 1990, The American journal of physiology.

[18]  J. Folkman,et al.  Isolation, characterization, and localization of heparin-binding growth factors in the heart. , 1990, The Journal of clinical investigation.

[19]  A. M. Lefer,et al.  Mediation of cardioprotection by transforming growth factor-beta. , 1990, Science.

[20]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[21]  W. Casscells,et al.  Culture‐induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells , 1991, Journal of cellular physiology.

[22]  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Orci,et al.  Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. , 1991, Biochemical and biophysical research communications.

[24]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[25]  L. Orci,et al.  Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. , 1992, Biochemical and biophysical research communications.

[26]  E. Bauer,et al.  Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.

[27]  A. Orlandi,et al.  Age-dependent increase of rabbit aortic atherosclerosis. A morphometric approach. , 1992, Pathology, research and practice.

[28]  Y. Uchida,et al.  Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. , 1992, Science.

[29]  J. Folkman,et al.  Control of angiogenesis by heparin and other sulfated polysaccharides. , 1992, Advances in experimental medicine and biology.

[30]  Martina,et al.  Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. , 1992, The Journal of clinical investigation.

[31]  S. Moncada,et al.  Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. , 1993, Cardiovascular research.

[32]  T. McCaffrey,et al.  Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. , 1993, Molecular biology of the cell.

[33]  P. Hall,et al.  Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. , 1993, Cardiovascular research.

[34]  M. Jaye,et al.  Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. , 1993, Circulation research.

[35]  N. Brindle.  Growth factors in endothelial regeneration. , 1993, Cardiovascular research.

[36]  T. Maki,et al.  Effects of dietary protein restriction on nitrogen balance and cardiovascular functions in aged rats. , 1993, Journal of gerontology.

[37]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[38]  C L Cooney,et al.  Heparinase inhibits neovascularization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Reiser,et al.  Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. , 1994, Journal of gerontology.

[40]  S. Reis,et al.  Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. , 1994, Circulation.

[41]  A. Cucina,et al.  Shear stress influences the release of platelet derived growth factor and basic fibroblast growth factor by arterial smooth muscle cells. Winner of the ESVS prize for best experimental paper 1993. , 1994, European journal of vascular surgery.

[42]  S. Epstein,et al.  Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. , 1994, The American journal of physiology.

[43]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[44]  M. Shibuya,et al.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.

[45]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[46]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[47]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[48]  G. Breier,et al.  Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.

[49]  M. Shibuya.  Role of VEGF-flt receptor system in normal and tumor angiogenesis. , 1995, Advances in cancer research.

[50]  G. Breier,et al.  Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells , 1995, FEBS letters.

[51]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[52]  P. Libby,et al.  Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[53]  K. Walgenbach,et al.  Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle , 1995, Nature Medicine.

[54]  J. Isner,et al.  Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. , 1995, Circulation.

[55]  A. Schmidt,et al.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.

[56]  L V McIntire,et al.  Shear stress and cyclic strain modulation of gene expression in vascular endothelial cells. , 1995, Blood purification.

[57]  J. Gamble,et al.  TGF-β and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells , 1995 .

[58]  M. Matsumoto,et al.  Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[60]  J. Isner,et al.  Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. , 1995, Circulation.

[61]  J. Martial,et al.  Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[63]  W. Schaper,et al.  Molecular mechanisms of coronary collateral vessel growth. , 1996, Circulation research.

[64]  M. Kitamura,et al.  Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells . , 1996, Journal of immunology.

[65]  P. Vallance,et al.  Local venous responses to endotoxin in humans. , 1996, Circulation.

[66]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[67]  A. Karsan,et al.  Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. , 1996, Blood.

[68]  K. Hirschi,et al.  Pericytes in the microvasculature. , 1996, Cardiovascular research.

[69]  R. Bucala,et al.  Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  P. Libby,et al.  Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon- , 1996, The Journal of Biological Chemistry.

[71]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[72]  C. Patterson,et al.  Suppression of Interleukin-1β-induced Nitric-oxide Synthase Promoter/Enhancer Activity by Transforming Growth Factor-β1 in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[73]  K. Alitalo,et al.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Cetrulo,et al.  Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. , 1997, Journal of molecular and cellular cardiology.

[75]  A. Matsumori,et al.  Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. , 1997, Circulation.

[76]  Janet Rossant,et al.  A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.

[77]  D. Rifkin,et al.  Biological roles of fibroblast growth factor-2. , 1997, Endocrine reviews.

[78]  J. Bischoff.  Cell adhesion and angiogenesis. , 1997, The Journal of clinical investigation.

[79]  M. Pepper,et al.  Manipulating angiogenesis. From basic science to the bedside. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[80]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[81]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[82]  P. Nawroth,et al.  Molecular mechanisms linking thrombosis and angiogenesis in cancer. , 1997, Trends in cardiovascular medicine.

[83]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[84]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[85]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[86]  J. Isner,et al.  Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.

[87]  S. Pawlowski,et al.  Fibroblast growth factor 2 control of vascular tone , 1998, Nature Medicine.

[88]  T. Libermann,et al.  Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[89]  M Duriez,et al.  Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[90]  T. Arakawa,et al.  Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. , 1998, Biochemical and biophysical research communications.

[91]  J. Michel,et al.  Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. , 1998, Experimental cell research.

[92]  J. Hoidal,et al.  Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.

[93]  K. Alitalo,et al.  Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[94]  C. Cheung.  Vascular Endothelial Gowth Factor Resulation of Fetal Membrane Vascularity : Implication in Amniotic Fluid Volume Regulation(第346回北里医学会招待学術講演会要旨) , 2000 .